NCT01631422View on ClinicalTrials.gov

A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

RO4602522

Single radiolabeled dose

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01631422 - A Single Dose Study of Radiolabeled RO4602522 in Healthy Volunteers | Biotech Hunter | Biotech Hunter